UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.76B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$447M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$336M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$294M |
| 5 |
GSK
GSK
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$937M |
| 2 |
UBS Group
UBS
|
+$511M |
| 3 |
Microsoft
MSFT
|
+$402M |
| 4 |
Baidu
BIDU
|
+$338M |
| 5 |
Apple
AAPL
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.08% |
| 2 | Consumer Discretionary | 6.75% |
| 3 | Financials | 6.3% |
| 4 | Healthcare | 5.83% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPYU
3026
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $3.31M | ﹤0.01% |
184,291
-254,452
| -58% | -$4.51M |
|
|
GBT
3027
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.31M | ﹤0.01% |
81,131
+71,410
| +735% | +$3.28M |
|
3028
CALL
Eastman Chemical
EMN
$8.42B
| $3.3M | ﹤0.01% |
+30,000
| New | +$3.26M |
|
3029
Fidelity MSCI Communication Services Index ETF
FCOM
$1.81B
| $3.29M | ﹤0.01% |
66,801
-4,011
| -6% | -$194K |
|
|
MIME
3030
DELISTED
Mimecast Limited
MIME
| $3.29M | ﹤0.01% |
81,933
+30
| +0% | +$1.32K |
|
3031
Rocket Pharmaceuticals
RCKT
$394M
| $3.29M | ﹤0.01% |
74,213
+28,048
| +61% | +$1.54M |
|
3032
FS KKR Capital
FSK
$3.44B
| $3.29M | ﹤0.01% |
165,841
+3,542
| +2% | +$65.9K |
|
3033
Steven Madden
SHOO
$3.55B
| $3.29M | ﹤0.01% |
88,154
-3,238
| -4% | -$118K |
|
|
ARI
3034
Apollo Commercial Real Estate
ARI
$885M
| $3.28M | ﹤0.01% |
234,701
-21,787
| -8% | -$280K |
|
3035
Fulton Financial
FULT
$4.64B
| $3.28M | ﹤0.01% |
192,482
+4,223
| +2% | +$65.4K |
|
3036
Myriad Genetics
MYGN
$312M
| $3.27M | ﹤0.01% |
107,524
+20,322
| +23% | +$577K |
|
3037
Invesco S&P MidCap 400 GARP ETF
GRPM
$509M
| $3.27M | ﹤0.01% |
36,713
+1,739
| +5% | +$147K |
|
3038
PUT
iShares MSCI China ETF
MCHI
$6.38B
| $3.27M | ﹤0.01% |
40,000
| – | – |
|
|
UCB
3039
United Community Banks
UCB
$4.28B
| $3.27M | ﹤0.01% |
95,792
+3,670
| +4% | +$121K |
|
|
EFC
3040
Ellington Financial
EFC
$1.71B
| $3.26M | ﹤0.01% |
203,329
+127,473
| +168% | +$2.01M |
|
3041
TD Synnex
SNX
$20.2B
| $3.25M | ﹤0.01% |
28,291
-5,117
| -15% | -$478K |
|
3042
MGIC Investment
MTG
$6.25B
| $3.25M | ﹤0.01% |
234,486
-77,151
| -25% | -$983K |
|
3043
EastGroup Properties
EGP
$10.9B
| $3.25M | ﹤0.01% |
22,655
-37,903
| -63% | -$5.31M |
|
|
FOLD
3044
DELISTED
Amicus Therapeutics
FOLD
| $3.25M | ﹤0.01% |
328,500
+61,602
| +23% | +$954K |
|
3045
SLM Corp
SLM
$5.15B
| $3.24M | ﹤0.01% |
180,509
-88,914
| -33% | -$1.35M |
|
|
FCT
3046
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $3.24M | ﹤0.01% |
264,178
-15,093
| -5% | -$180K |
|
3047
KB Financial Group
KB
$43.5B
| $3.24M | ﹤0.01% |
65,517
+6,433
| +11% | +$268K |
|
3048
TFI International
TFII
$11.5B
| $3.24M | ﹤0.01% |
43,320
-9,020
| -17% | -$613K |
|
3049
Cirrus Logic
CRUS
$6.26B
| $3.24M | ﹤0.01% |
38,185
+171
| +0.4% | +$14.8K |
|
3050
NNN REIT
NNN
$8.99B
| $3.23M | ﹤0.01% |
73,394
-24,102
| -25% | -$1.01M |
|
Similar funds
UBS Group's Q1 2021 Portfolio in Review
As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,391 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
- UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
- UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
- UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
- UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
- UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
- UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.